GMED vs HAE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Apr 02, 2026

GMED

64.2
AI Score
VS
GMED Wins

HAE

62.0
AI Score

Investment Advisor Scores

GMED

Apr 02, 2026
64score
Recommendation
BUY

HAE

Apr 02, 2026
62score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric GMED HAE Winner
Forward P/E 19.3424 10.3199 HAE
PEG Ratio 1.7253 0.8599 HAE
Revenue Growth 25.7% -2.7% GMED
Earnings Growth 437.0% 28.4% GMED
Tradestie Score 64.2/100 62.0/100 GMED
Profit Margin 18.3% 13.3% GMED
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY BUY Tie

Frequently Asked Questions

Based on our detailed analysis, GMED is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.